2008
DOI: 10.1016/j.imbio.2008.07.024
|View full text |Cite
|
Sign up to set email alerts
|

An improved method to generate equine dendritic cells from peripheral blood mononuclear cells: Divergent maturation programs by IL-4 and LPS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
13
2

Year Published

2009
2009
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(17 citation statements)
references
References 20 publications
2
13
2
Order By: Relevance
“…Considering that 82.6% of the CD14+ cells were expressing the surface marker eqMHCII 4 days after selection, using this percentage and the number of vital CD14+ cells, our DC outcome was 14.78 × 10 6 DCs from 70 ml of blood resulting in 21.1 × 10 6 DCs from 100 ml of blood (82.6% × [28.7 × 10 6 cells] × [89% vital cells]) = 14.78 × 10 6 DCs/70 ml blood) (Table 3). Results show that the herein DC outcome is 2‐fold higher than the previous outcome of 10 × 10 6 DCs/100 ml blood reported [10].…”
Section: Resultscontrasting
confidence: 65%
See 1 more Smart Citation
“…Considering that 82.6% of the CD14+ cells were expressing the surface marker eqMHCII 4 days after selection, using this percentage and the number of vital CD14+ cells, our DC outcome was 14.78 × 10 6 DCs from 70 ml of blood resulting in 21.1 × 10 6 DCs from 100 ml of blood (82.6% × [28.7 × 10 6 cells] × [89% vital cells]) = 14.78 × 10 6 DCs/70 ml blood) (Table 3). Results show that the herein DC outcome is 2‐fold higher than the previous outcome of 10 × 10 6 DCs/100 ml blood reported [10].…”
Section: Resultscontrasting
confidence: 65%
“…Directly after PBMC isolation an additional cell selection step was introduced using a human CD14 mAb. The equine CD14 positive cells were selected and cultured applying the recommended cytokine concentrations for DC generation [10].…”
Section: Discussionmentioning
confidence: 99%
“…Peripheral blood mononuclear cells (PBMC) were isolated via 1077 Ficoll-Paque (Amersham Biosciences, Piscataway, NJ) density centrifugation at 700 ϫ g for 15 min. We modified previously described magnetic bead positive selection and plastic adherence protocols to perform monocyte isolation (12,46). Briefly, 10 8 PBMC were labeled with anti-equine CD14 monoclonal antibody (MAb; hybridoma clone 105, kindly provided by Bettina Wagner, Cornell University, Ithaca, NY) (26), washed with phosphate-buffered saline (PBS), incubated with anti-mouse IgG1 microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany), and positively selected over an LS column (Miltenyi Biotech) according to the manufacturer's protocol.…”
Section: Methodsmentioning
confidence: 99%
“…Interestingly, the AMLR displays characteristics of a normal immune response (including specificity and memory) and is reduced in a variety of human disease states (23, 53). Furthermore, the self-reactive T cells in the AMLR demonstrate a capacity for immunosuppression and increased transcription of the Treg transcription factor FOXP3, suggesting that such DC-stimulated T cells are involved in immune regulation during the normal immune response in vivo (25,45,51).A protocol for generating monocyte-derived DCs has been described in the horse, and the phenotype of these cells has been characterized by several groups (9,12,19). However, relatively little is known about the ability of equine DCs to induce proliferation and differentiation of autologous T cells.…”
mentioning
confidence: 99%
See 1 more Smart Citation